Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) today announced the Company’s Board of Directors has appointed independent director Ann Merrifield to the newly created position …
Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced that a third patient has been enrolled in the company’s ongoing pilot trial of its investigational Neuro-Spinal …
Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) has announced that the company’s investigational Neuro-Spinal Scaffold was featured on NBC’s TODAY show this morning. Two patients …
Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced that the company’s investigational Neuro-Spinal Scaffold has received the 2015 Becker’s Healthcare Spine Device Award. It is …
Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) announced a six-month post-implant update for the first study patient and a three-month post-implant update for the second …
In a research report released April 17, H.C.
